Volunteers are the heart of Rally's mission!
Rally Kid Keren is a True Advocate
“I have been fighting cancer and the side effects since 2017,” shares Rally Kid Keren, who beat rhabdomyosarcoma almost five years before...
Success Stories
read more
What is Charity Navigator?
When you are in the market for a new refrigerator, you ask your neighbors and friends for recommendations, and maybe even consult Consumer...
$56 Million In New Federal Funding
ATLANTA (September 1, 2022) – After six years of intense advocacy with Department of Defense (DOD) Subcommittee members, Rally Foundation...
New and Innovative Study Technique for Osteosarcoma Metastasis
Osteosarcoma (OS) is a type of cancer that begins in the cells that form bones, and mainly affects teenagers and young adults. In...
INSTRuCT Database for Rhabdomyosarcoma Impact
Rally is proud to be the initial funder for the creation of the INSTRuCT Database with a Consortium Grant to Dr. Sam Volchenboum of the...
New RNA Therapies for Glioblastoma from Small Phase 1 Study
Glioblastoma (GBM) in children and adults is a deadly brain tumor with a poor prognosis. Current treatment includes surgery to remove as...
AML Treatment Developments
Rally Foundation for Childhood Cancer Research is excited to announce new developments in the treatment of childhood acute myeloid...
The New England Journal of Medicine
Chills ran up and down my arms when I opened the link that Rally-funded researcher Dr. Gregory Friedman sent. I was staring at the New...
How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2
Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and...
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’
Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug...
Success Stories
Rally Kid Keren is a True Advocate
“I have been fighting cancer and the side effects since 2017,” shares Rally Kid Keren, who beat rhabdomyosarcoma almost five years before being diagnosed with a completely different cancer, osteosarcoma, in 2021. Dealing with this new cancer diagnosis has been a hard road for Keren and her family. They have found a way of understanding and coping with the harsh treatments and difficult procedures. Just ask for clarification. Keren’s mom Kelly proudly explains, “Keren has really learned how to...
What is Charity Navigator?
When you are in the market for a new refrigerator, you ask your neighbors and friends for recommendations, and maybe even consult Consumer Reports to see different ratings. When you want to donate to a charity, how do you decide if the charity will take care of your donation and use your donation to meet its mission? Charity Navigator has been called the Consumer Reports of the nonprofit world. It is the largest charity evaluator in America. Its website attracts more visitors than all other...
$56 Million In New Federal Funding
ATLANTA (September 1, 2022) – After six years of intense advocacy with Department of Defense (DOD) Subcommittee members, Rally Foundation for Childhood Cancer Research is excited to announce $56 million in new federal funding this year for cancers affecting children, adolescents, and young adults (AYAs). The $56 million is being awarded from the DOD Congressionally Directed Medical Research Programs’ (CDMRP) Peer Reviewed Cancer Research Program directly to researchers, funding 44 projects....
New and Innovative Study Technique for Osteosarcoma Metastasis
Osteosarcoma (OS) is a type of cancer that begins in the cells that form bones, and mainly affects teenagers and young adults. In metastatic osteosarcoma, the cancer spreads from the primary bone site to another location, most often the lungs. It can also spread to other bones, the brain or other organs. Currently there are no curative treatments for metastatic osteosarcoma. We urgently need to develop new therapies. To better understand a disease, it is common for tumor research studies to...
INSTRuCT Database for Rhabdomyosarcoma Impact
Rally is proud to be the initial funder for the creation of the INSTRuCT Database with a Consortium Grant to Dr. Sam Volchenboum of the Pediatric Cancer Data Commons (PCDC) at the University of Chicago. Recent advances in genomic medicine look promising in the study of rhabdomyosarcoma (RMS). RMS is a rare soft tissue malignancy primarily diagnosed before adolescence. RMS studies are historically challenged, given that only approximately 350 patients are diagnosed with RMS each year in the...
New RNA Therapies for Glioblastoma from Small Phase 1 Study
Glioblastoma (GBM) in children and adults is a deadly brain tumor with a poor prognosis. Current treatment includes surgery to remove as much of the tumor as possible, followed by radiation and chemotherapy. Unfortunately, most patients still experience tumor growth despite the treatment and have a median survival of less than two years. Immunotherapy has shown success in the treatment of other types of tumors, but that success has been elusive with malignant brain tumors, such as GBM....